Duncan Jarvies

Welcome back to Talk Evidence, your monthly roundup of the world of EBM.

I'm Doug Jovis, multimedia editor here at the BMJ, and I'm joined in the studio by Helen MacDonald.

Helen, can I get you to introduce yourself?

And we are joined on the phone by Carl Hennigan, who is currently in quarantine in Oxford.

Carl, can I get you to introduce yourself?

Well, I hope you get better soon, and I'm sure everyone listening does as well.

Maybe it'll keep him a little bit more quiet this week, Helen.

Yeah, we can.

Saying that, we are about to go straight over to Carl to do our first start and stop.

Carl, you've been looking at corticosteroids for treating sepsis in children and adults.

So you think it's strong enough to potentially start doing that already, the evidence?

Absolutely.

And as you said there, Carl, these are the kind of things that we need to get into practice.

And that's exactly what our next article, Helen, is all about.

So what was that emerging evidence?

Absolutely.

Great.

Well, so there we go.

That is a nice, simple, relatively simple thing to start doing.

The next one, Carl, I'm slightly surprised when you put this on the list, but it's interesting.